Khiron Life Sciences Corp. (TSXV: KHRN) (OTC Pink: KHRNF) and 2518542 Alberta Ltd., a company controlled by Avonlea Drewry Holdings Inc., have entered into an amended and restated share purchase agreement, related to the sale of Khiron's European subsidiaries
Khiron, the Global Leader in Medical Cannabis Launches New Cannabis Products in Europe including Stellar Genetics from California businessinsider.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from businessinsider.com Daily Mail and Mail on Sunday newspapers.
PharmaDrug Inc said it has agreed to sell its German medical cannabis distributing subsidiary Pharmadrug Production GmbH to Khiron Life Sciences Corp in.
Toronto, Ontario (Newsfile Corp. - May 31, 2022) - PharmaDrug Inc. (CSE: PHRX) (OTCQB: LMLLF) ("PharmaDrug" or the "Company"), is pleased to announce that it has entered into an agreement on May 31,